piracetam has been researched along with losartan potassium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Farooq, MU; Gupta, R; Kassab, M; Majid, A; Reeves, M; Zemke, D | 1 |
| Cilio, MR; Ferriero, DM | 1 |
1 review(s) available for piracetam and losartan potassium
| Article | Year |
|---|---|
Synergistic neuroprotective therapies with hypothermia.
Topics: Acetylcysteine; Anticonvulsants; Body Temperature; Cannabinoids; Combined Modality Therapy; Erythropoietin; Fructose; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Levetiracetam; Melatonin; Neuroprotective Agents; Piracetam; Topiramate; Xenon | 2010 |
2 other study(ies) available for piracetam and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of anticonvulsant drugs on the fibrinolytic activity of tissue plasminogen activator.
Topics: Adult; Anticonvulsants; Blood Coagulation; Drug Interactions; Erythropoietin; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Levetiracetam; Male; Phenobarbital; Phenytoin; Piracetam; Recombinant Proteins; Tissue Plasminogen Activator; Valproic Acid | 2008 |